Kestra Medical Technologies, Ltd.: Business Overview, Financials & Competitive Analysis
Kestra Medical Technologies, Ltd. scores 7/10 on the AskCyborg Cyborg Score (Solid). High-growth cardiovascular wearable device company with strong revenue acceleration and analyst backing, but requiring path to profitability before achieving investment-grade status. FY2025 revenue reached $59.82 million, an increase of 115.05% year-over-year, demonstrating strong market traction in a high-growth segment. However, losses were -$126.14 million, 25.1% more than in.
What is Kestra Medical Technologies, Ltd.'s industry? Kestra Medical Technologies, Ltd. (kestramedical.com) operates in Wearable Medical Devices / Digital Healthcare / Cardiovascular Medical Device. AskCyborg classifies Kestra Medical Technologies, Ltd. under Wearable Medical Devices / Digital Healthcare / Cardiovascular Medical Device in its company registry.
Kestra Medical Technologies operates as a wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technol...
Cyborg Score thesis
High-growth cardiovascular wearable device company with strong revenue acceleration and analyst backing, but requiring path to...
Read the full analyst-debate transcript →Get the Latest Kestra Medical Technologies, Ltd. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeKestra Medical Technologies, Ltd. Overview
Pro stress-test →Kestra Medical Technologies operates as a wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. The company develops and commercializes the Cardiac Recovery System platform, which integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Strategic Profile
Pro stress-test →The flagship ASSURE WCD is a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest, accompanied by a suite of integrated digital solutions and services. Its integrated approach combining advanced monitoring, real-time therapeutic intervention, and comprehensive digital health support differentiates it in the competitive landscape of medical device technology.
Competitive Landscape
Pro stress-test →Kestra competes against approximately 40 competitors including CardioDiagnostics and other cardiac monitoring/therapeutic device companies. The company differentiates through its integrated platform combining wearable hardware with digital health services and clinical support, rather than point solutions. Primary competitors include traditional ICD manufacturers and emerging digital cardiac care platforms.
Industry Context
Kestra Medical Technologies, Ltd. operates in Wearable Medical Devices / Digital Healthcare / Cardiovascular Medical Device.
Key facts
Founded: 2014 · Headquarters: Kirkland, Washington, United States · Revenue: $59.82M (FY2025) · Market cap: $1.2B